Literature DB >> 1762774

Surgical landmarks for the facial nerve.

S J Wetmore1.   

Abstract

A number of different approaches can be used to expose the facial nerve. The route taken will depend on the pathology and the portion of the nerve that requires exposure. When performing a parotidectomy approach to the extratemporal portion of the facial nerve, the tragal pointer is a key landmark, but other landmarks also should be used to identify the facial nerve safely. The lateral semicircular canal, the chorda tympani nerve, the digastric ridge, and the cochleariform process are some of the useful landmarks in the mastoid and middle ear. When performing a middle fossa approach, the superior semicircular canal, the greater petrosal nerve, and a window through the tegmen tympani into the attic are useful guideposts. The surgeon should use as many of the available landmarks as feasible to perform safe facial nerve surgery.

Entities:  

Mesh:

Year:  1991        PMID: 1762774

Source DB:  PubMed          Journal:  Otolaryngol Clin North Am        ISSN: 0030-6665            Impact factor:   3.346


  4 in total

1.  Landmarks of the facial nerve: implications for parotidectomy.

Authors:  N Pather; M Osman
Journal:  Surg Radiol Anat       Date:  2006-04-20       Impact factor: 1.246

2.  Analysis of axial temporal bone computed tomography scans for performing a safe posterior tympanotomy.

Authors:  Chang Woo Kim; So Jung Oh; Han-Shin Kim; Seung-Hern Ha; Young-Soo Rho
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-12-20       Impact factor: 2.503

3.  Our Experience of Anatomical Variations of Facial Nerve in Cadaveric Temporal Bone Dissection.

Authors:  Sonali Praful Jatale; Sambhaji Govind Chintale; Vilas Rambhau Kirdak; Kaleem Azimoddin Shaikh
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2020-07-20

4.  Evaluation of the Relationship Between Facial Nerve and Lateral Semicircular Canal in the Posterior Tympanotomy Approach.

Authors:  Ismail Yilmaz; Serhat Inan; Omer Vural; Volkan Akdogan; Evren Hizal; Fulya Ozer; Haluk Yavuz; Levent Naci Ozluoglu
Journal:  J Int Adv Otol       Date:  2022-01       Impact factor: 1.316

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.